GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>I would be surprised if we saw a US partnership materialize until after the final patient has been treated and the rATIII data from the HD phase III trial is completed.<

I doubt that the 17th patient is holding up the consummation of a partnership deal. Data analysis of the trial results ought to be something a prospective partner has permission to do under a non-disclosure agreement.